Clinical impact and cost-effectiveness of split-septum and single-use prefilled flushing device vs 3-way stopcock on central line-associated bloodstream infection rates in India: a randomized clinical trial conducted by the International Nosocomial Infect

The use of SS + SUF is cost-effective and associated with a significantly lower CLABSI rate compared with the use of 3WSC.